Omeragic A, Kayode O, Hoque MT, Bendayan R
Frohnert BI, Sinaiko AR, Serrot FJ, Foncea RE, Moran A, Ikramuddin S, et al
Morgan Wealth ManagementNew YorkNew York - NYC (High Net Worth)$1M$919M$300K-3M$300K-3MProfile SpotlightTom KlingmanKlingman & AssociatesNew YorkNew York - NYC (High Net Worth)$2M$4B$5-50M$3-40MLisa CollettiAspiriantNew YorkNew York - NYC (High Net Worth)$1.5M$16.1B$3-200M$1.5-25MAnthony PellarinWells Fargo AdvisorsNew YorkNew York - NYC (High Net Worth)$2M$5.2B$4-30M$3-10MProfile SpotlightLou CannataroCannataro Family Capital Partners | Northwestern MutualNew YorkNew York - NYC (High Net Worth)$0$1.7B$2-75M$750K-25MSharon CunninghamMorgan Stanley Wealth ManagementNew YorkNew York - NYC (High Net Worth)$1M$1.2B$3.5-15M$1-3.5MProfile SpotlightThomas Edward CavadaUBS Wealth ManagementNew YorkNew York - NYC (High Net Worth)$1M$688M$2-10M$1-8MKen MayerMorgan Stanley Wealth ManagementNew YorkNew York - NYC (High Net Worth)$500K$1.8B$2-15M$1-10MProfile SpotlightJames TilleyJ.P
Obesity and its comorbidities, current treatment options and future perspectives: challenging bariatric surgery
Telehealth Call 3
Sie sind nicht zugelassen, werden dennoch verkauft und oft unter dem Vorwand fr Forschungszwecke vertrieben